Lupus erythematosus and nutrition: a review of the literature.
The purpose of this review was to search the scientific literature for dietary compounds that alleviate or exacerbate symptoms of lupus erythematosus (LE) in both animal and human models. A detailed literature review was undertaken to find articles showing a relationship between LE and nutrition by using MEDLINE/INDEX MEDICUS (1950-March 2000) for English-language articles, followed by cross-referencing. Aggravating substances appear to include excess calories, excess protein, high fat (especially saturated and omega-6 polyunsaturated fatty acids), zinc, iron, and L-canavanine found in alfalfa tablets. Possible beneficial dietary compounds include vitamin E, vitamin A (beta-carotene), selenium, fish oils (omega-3 polyunsaturated fatty acids), evening primrose oil, flaxseed, a plant herb (Tripterygium wilfordii), dehydroepiandrosterone, and calcium plus vitamin D (if taking corticosteroids). Some people with systemic LE placed on food allergy elimination diets reported improvement in their LE symptoms; however, this may be related to a decrease of other substances in the diet. Also, although no direct evidence was reported on the beneficial effects of either bromelain or a vegetarian diet (possibly allowing fish), it is suggested that they might be beneficial. Limitations to this research are that the findings are based on relatively few studies, many of which were without control groups or extrapolated from animal models. No large-scale studies have been performed with LE patients to substantiate the benefit, if any, of these individual dietary interventions, and if they were conducted, the remission and exacerbation pattern of LE may interfere with elucidating their effectiveness. Also, dietary changes should not be attempted without a physician's approval/monitoring.
Brown
A C
AC
Department of Human Nutrition, Food, & Animal Sciences, University of Hawaii at Manoa, Honolulu, HI 96822, USA.
D000818:Animals; D004032:Diet / Q000009:adverse effects; D004041:Dietary Fats / Q000008:administration & dosage / Q000009:adverse effects; D004044:Dietary Proteins / Q000008:administration & dosage / Q000009:adverse effects; D004195:Disease Models, Animal; D002149:Energy Intake; D005395:Fish Oils / Q000627:therapeutic use; D019597:Flax / Q000627:therapeutic use; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D019266:Iron, Dietary / Q000008:administration & dosage / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000178:diet therapy* / Q000503:physiopathology*; D016239:MEDLINE; D019684:Magnoliopsida / Q000627:therapeutic use; D000455:Medicago sativa / Q000009:adverse effects; D051379:Mice; D008903:Minerals / Q000008:administration & dosage; D009747:Nutritional Physiological Phenomena; D008517:Phytotherapy; D010938:Plant Oils / Q000627:therapeutic use; D014815:Vitamins / Q000008:administration & dosage; D015032:Zinc / Q000172:deficiency
D004041:Dietary Fats; D004044:Dietary Proteins; D005395:Fish Oils; D006728:Hormones; D019266:Iron, Dietary; D008903:Minerals; D010938:Plant Oils; D014815:Vitamins; D015032:Zinc